CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

A major goal of the transplant field is to tolerize donor T cells to prevent graft-versus-host disease (GVHD) (1). We describe an ex vivo approach in which the blockade of CD40 ligand (CD40L:CD154):CD40 interactions, a pathway required for optimal T cell expansion, induces donor CD4(+) T cells to be...

Full description

Saved in:
Bibliographic Details
Main Authors: Blazar, B R, Taylor, P A, Noelle, R J, Vallera, D A
Format: Artigo
Language:Inglês
Published: 1998
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC508907/
https://ncbi.nlm.nih.gov/pubmed/9691083
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items